Abstract

Myosin VI contains an inserted sequence that is unique among myosin superfamily members and has been suggested to be a determinant of the reverse directionality and unusual motility of the motor. It is thought that each head of a two-headed myosin VI molecule binds one calmodulin (CaM) by means of a single “IQ motif”. Using truncations of the myosin VI protein and electrospray ionization(ESI)-MS, we demonstrate that in fact each myosin VI head binds two CaMs. One CaM binds to a conventional IQ motif either with or without calcium and likely plays a regulatory role when calcium binds to its N-terminal lobe. The second CaM binds to a unique insertion between the converter region and IQ motif. This unusual CaM-binding site normally binds CaM with four Ca2+ and can bind only if the C-terminal lobe of CaM is occupied by calcium. Regions of the MD outside of the insert peptide contribute to the Ca2+–CaM binding, as truncations that eliminate elements of the MD alter CaM binding and allow calcium dissociation. We suggest that the Ca2+-CaM bound to the unique insert represents a structural CaM, and not a calcium sensor or regulatory component of the motor. This structure is likely an integral part of the myosin VI “converter” region and repositions the myosin VI “lever arm” to allow reverse direction (minus-end) motility on actin.
Myosin VI was the first myosin demonstrated to move toward the pointed (minus) end of an actin filament (1). This discovery was based on the hypothesis that reverse direction would require a redesign of the domain of myosin, known as the converter, that rotates on changes in the state of the nucleotide binding pocket and actin–myosin interface. The converter is attached directly to what is known as the myosin “lever arm,” which is made up of a variable number of “IQ motifs” that are binding sites for calmodulin (CaM) or specialized myosin light chains (2). This lever arm effectively amplifies the movements of the converter, and thus the step size of most myosins is thought to be a function of lever arm length (35). Myosin VI contains a unique insertion between the converter and its single IQ motif (6). Cryo-electron microscopy revealed that the myosin VI lever arm points toward the pointed (minus) end of the actin filament, and motility assays showed that the motor moves toward the minus end of the actin filament (1). Based on this finding, it was suggested that this unique insert is involved in altering the converter to reposition the lever arm.
Since the lever arm region of each head of the myosin VI dimer consists of a single IQ motif, it has been assumed that the lever arm contains one CaM. Because, for both myosin II and myosin V, the length of the lever arm has been shown to correspond to the step size associated with a single ATPase cycle (5, 7, 8), myosin VI would be expected to have a small (≈5 nm) step size. However, single molecule experiments with optical tweezers revealed that myosin VI has a broad distribution of step sizes centered on 30 nm (9), which is not consistent with a simple lever arm as defined by the number of IQ motifs. Thus, to understand the mechanism of directionality and large step size of myosin VI, further characterization of the structures flanking the IQ motif is necessary.
We began to address this problem by first truncating the myosin VI molecule to produce a molecule with the motor domain (MD) (including the converter) and insert, but with the IQ motif removed. Surprisingly, CaM bound to this construct. We then used electrospray ionization (ESI)-MS to determine the true CaM and calcium stoichiometry of various myosin VI fragments in the presence of either EGTA or high Ca2+ concentrations. We then further characterized Ca2+–CaM binding using fluorescence of intrinsic tryptophans (trp) within the insert and IQ motif peptides.

Experimental Procedures

Myosin VI Expression and Purification. To create a series of single-headed myosin VI constructs, porcine myosin VI WT cDNA (6) was truncated either immediately after the converter (Asp-773; MD), after the unique insert (Ala-816; MD plus insert), after the IQ motif (at Gly-839; M6-S1), or before the beginning of the high probability coiled coil region (Lys-917; M6-long S1). Additional constructs that begin with the myosin VI converter (Pro-706) and end either after the insert (Ala-816; converter plus insert) or after the IQ motif (Gly-839; converter plus insert plus IQ) were also produced. For each construct, a Flag tag (encoding GDYKDDDDK) was inserted at the N terminus (MD, MD plus insert, and converter plus insert) or the C terminus (M6-S1, M6-long S1, and converter plus insert plus IQ) to facilitate purification (10). A schematic summary of all constructs is shown in Fig. 1.
Fig. 1.
Schematic diagrams of the constructs used in this study. These diagrams of myosin VI reflect our current findings. The insert adjacent to the converter is depicted with a CaM and four Ca2+ bound to it (yellow dots). The CaM bound to the IQ motif is depicted as being in the apo form, and followed by a region of unknown structure, which is in turn followed by the coiled coil and globular targeting domain. Three major structural states have been depicted for the CaM lobes. When Ca2+ is bound, the N- and C-lobe of CaM adopt the open conformation. In the apo-form, the N- and C-lobe adopt a closed and semiopen conformation, respectively (20).
Expression of the recombinant single-headed fragments of myosin VI was accomplished by means of infection of SF9 insect cells with a viral expression vector (baculovirus) capable of driving high-level expression of foreign proteins. The SF9 cells were coinfected with recombinant virus expressing the myosin VI heavy chain (HC) and a recombinant virus expressing either CaM or calcium-binding mutants of CaM (below). Details of the protein expression and purification have been published (1, 11).
CaM and CaM Mutants. The generation of CaM mutants with either the N- or C-terminal calcium-binding sites eliminated has been described (12). Calcium binding is abolished by mutation of the C-terminal lobe of chicken CaM (E104A and E140A), or the N-terminal lobe of CaM (E31A and E67A). The mutant cDNA constructs were then inserted into viral expression vectors for cotransfection with the myosin VI constructs or into bacterial expression vectors for coexpression with a construct containing the myosin VI converter plus insert or converter plus insert plus IQ. For peptide-binding experiments, bacterial expressed CaM and mutants were made Ca2+-free by incubating with 10 mM EGTA and then loading them onto a Superdex 200 Prep Grade Gel Filtration column (Pharmacia Biotech) equilibrated with the buffer 50 mM Mops (pH 7), 100 mM KCl, 2 mM EGTA, and 1 mM DTT.
Peptides. Peptides corresponding to the unique insert or IQ motif of pig myosin VI were synthesized by the protein analysis core of the Boston Biomedical Research Institute and were end-protected by N-terminal acetylation and C-terminal amidation. The insert peptide (Ac-KRVNHWLICSRWKKVQWCSLSVIKLKNKI-NH2) had three trps whereas the IQ peptide (Ac-KYRAEACIKMQKTIRMWLCKRRHKPRID-NH2) had only one.
ESI-MS. Before MS analysis, the samples were desalted on nanosep 3Komega microconcentrators (Pall) in 50 mM ammonium acetate (pH 7). Eight dilution/concentration steps were performed at 4°C and 10,000 g/min. Ammonium acetate enables native structures of proteins to be preserved and is compatible with ESI-MS analysis. ESI-MS measurements were performed either on an ESI-time-of-flight (TOF) (LCT, Micromass, Altrincham, U.K.) or on a ESI-quadrupole (Q)-TOF (Q-TOF II, Micromass) mass spectrometers. Both instruments were fitted with standard Z-spray source and have extended mass range of 42,000 m/z for the LCT and 25,000 m/z for the Q-TOF II. In the case of the hybrid Q-TOF instrument, mass spectra were recorded at the exit of the TOF analyzer by using the first quadrupole in the “rf-only” mode. Calibration was performed in the positive ion mode by using horse heart myoglobin. Purity of samples was first estimated by mass analysis in denaturing conditions: samples were diluted to 2 pmol/μl in a 1:1 water: acetonitrile mixture (vol/vol) acidified with 1% formic acid. In these conditions the noncovalent interactions are disrupted, which allows the measurement of the molecular weight of each species with high precision (better than 0.01%).
For analysis in native conditions, samples were diluted to 10 pmol/μl in 50 mM ammonium acetate buffer. Great care was exercised to ensure that the noncovalent interactions survive the ionization/desorption process. In particular, atmospheric pressure/vacuum interface parameters were optimized to obtain the best sensitivity and spectrum quality without affecting the stability of the noncovalent complexes. The accelerating voltage applied on the sample cone ranged from 30 to 200 V, and both source and desolvation temperatures were 80°C. For the various myosin VI preparations, several ESI-MS and collision-induced dissociation MS experiments were performed. Table 1 summarizes the conclusions of these experiments and describes the mass of the species found in solution.
Table 1.
Summary of the ESI-MS and collision-induced dissociation MS experiments performed on various myosin VI constructs describing the mass (Da) of the species found in solution
 Denatured conditions As prepared*Ca2+ conditions (addition of 100 μM Ca Acetate)
MD-Ins (5mM EGTA)*94,203 ± 3HC111,071 ± 11HC + CaM + 4 Ca2+111,079 ± 7HC + CaM + 4 Ca2+
 16,722 ± 0.3CaM No free CaM in solution No free CaM in solution
M6-S1 (5 mM EGTA)*97,083 ± 2HC130,675 ± 7HC + 2 CaM + 4 Ca2+244,784 ± 42 HC + 3 CaM + 12 Ca2+
 16,722 ± 0.4CaM113,949 ± 6HC + 1 CaM + 4 Ca2+130,824 ± 4HC + 2 CaM + 8 Ca2+
   16,721 ± 0.4Free CaM + 0 Ca2+113,948 ± 5HC + 1 CaM + 4 Ca2+
     16,874 ± 0.5Free CaM + 4 Ca2+
M6-S1/ELC (5 mM EGTA)*97,081 ± 3HC131,054 ± 6HC + CaM + ELC + 4 Ca2+  
 16,722 ± 0.4CaM113,955 ± 7HC + CaM + 4 Ca2+  
 17,111 ± 0.5ELC17,112 ± 0.4Free ELC  
Conv-Ins (1 mM EGTA)*14,483 ± 0.1HC31,358 ± 0.3HC + CaM + 4 Ca2+31,358 ± 0.3HC + CaM + 4 Ca2+
 16,722 ± 0.3CaM31,282 ± 0.3HC + CaM + 2 Ca2+16,874 ± 0.4Free CaM + 4 Ca2+
   16,722 ± 0.3Free CaM + 0 Ca2+  
Conv-Ins-IQ (1 mM EGTA)*18,377 ± 0.1HC51,897 ± 0.2HC + 2 CaM + 2 Ca2+52,124 ± 1HC + 2 CaM + 8 Ca2+
 16,722 ± 0.2CaM35,174 ± 1.2HC + 1 CaM + 2 Ca2+35,251 ± 2HC + 1 CaM + 4 Ca2+
   16,722 ± 0.5Free CaM + 0 Ca2+16,873 ± 1Free CaM + 4 Ca2+
     69,002 ± 1HC + 3 CaM + 12 Ca2+
     104,254 ± 22HC + 4 CaM + 16 Ca2+
M6-Long S1 (no Ca2+ or EGTA)*107,132 ± 2HC140,729 ± 7HC + 2 CaM + 4 Ca2+140,873 ± 7HC + 2 CaM + 8 Ca2+
 16,722 ± 0.3CaM No free CaM in solution No free CaM in solution
Bold characters refer to myosin VI complexes in solution; regular characters indicate dissociated species from myosin VI complexes. Ins, insert; Conv, converter.
*
Final concentration of Ca2+ or EGTA added during the purification of the protein.
EGTA treatments were carried out by incubating samples 30 min in the desired EGTA concentration buffer. Before MS analysis, excess EGTA was eliminated by desalting the samples with eight steps of dilution/concentration.
Trp Fluorescence Studies. All fluorescence measurements were performed on a Perkin–Elmer LS5 Spectrofluorometer at 20°C. The peptide concentrations were determined spectrophotometrically by using calculated ε280 values of 6,970 M–1·cm–1 (IQ peptide) and 17,070 M–1·cm–1 (insert peptide). The concentrations of CaM were also determined spectrophotometrically by using ε279 = 1,874 M–1·cm–1 (13). Titration curves were performed in 50 mM Mops (pH 7), 100 mM KCl, 1 mM DTT, and either 1 mM CaCl2 or 2 mM EGTA, as appropriate. Direct fluorometric titrations of the peptide were performed at λemission = 340 or 345 nm for the Ca2+ and EGTA curves, respectively, by using λexcitation = 295 nm. Fluorescence changes produced by CaM binding to the myosin VI peptides were fit to Eq. 1,
\begin{equation*}\;F=\{{\alpha}(([P]+[CaM]+K_{{\mathrm{d}}})-\sqrt{([P]+[CaM]+K_{{\mathrm{d}}})^{2}-4{\cdot}[P]{\cdot}[CaM]}\}/2,\;\end{equation*}
[1]
where F is the trp fluorescence intensity, α is a scaling factor for converting concentration to fluorescence intensity, [P] is the calculated concentration of myosin VI peptide, [CaM] is CaM concentration, and Kd is the dissociation constant for construct binding to CaM. In the absence of cooperativity, and with 1:1 peptide:CaM binding stoichiometry, [P] is equal to the measured peptide concentration. In contrast, a 1:2 peptide:CaM stoichiometry would be reflected in a value of [P] that is half the actual peptide concentration.

Results

Binding of CaM to Myosin VI-S1. As shown in Fig. 2A, myosin VI containing both the insert and IQ motif (M6-S1), or the construct that deletes the IQ motif but retains the insert (MD plus insert), can bind CaM. Removal of both the insert and IQ motif (MD) abolishes all CaM binding. To ascertain the subunit composition of the different constructs, we used ESI-MS, which has emerged as a powerful tool for the investigation of supramolecular complexes (14, 15). Moreover, recent studies showed the potential of MS for the studies of CaM–peptide complexes and CaM–calcium interaction (16). For each of these myosin VI constructs, this technique allowed us to determine not only the CaM stoichiometry, but also the stoichiometry of the calcium bound to each CaM. Representative spectra are shown in Fig. 3A whereas all of the ESI-MS data are summarized in Table 1.
Fig. 2.
SDS/PAGE gel of myosin VI fragments expressed with CaM. (A) Lane 1 depicts the purified myosin VI MD from which both the unique insert and IQ motif have been removed. It was coexpressed in SF9 cells with CaM. Note that CaM did not bind to this construct. Lane 2 contains the purified MD that contains the unique insert after the converter (MD plus insert) and demonstrates that this construct binds CaM. Lane 3 is the myosin VI-S1 (M6-S1), which consists of MD, insert, and IQ motif. It also binds CaM. The fact that it binds only CaM is shown by the calcium-induced shift of CaM mobility in lane 4. Lane 4 contains the same sample as in lane 3, but with EGTA removed. Lanes 5 and 6 are purified CaM in the presence of either EGTA or calcium. (B) A magnified view of the CaM-containing region of a gel of purified myosin VI-S1 (M6-S1) complexes that were produced by HC coexpression with either N-terminal mutant (E31A; E67A) CaM, C-terminal mutant CaM (E104A; E140A), or WT chicken CaM. In the presence of EGTA, all CaM species migrated similarly. In the presence of Ca2+, the WT CaM migrates faster than either mutant. This result demonstrates that both the insert and IQ of the M6-S1 can bind the N-terminal mutant CaM, but the C-terminal mutant CaM can bind only to one of the two CaM-binding sites. In the case of expression of the C-terminal mutant, the WT CaM bound to the M6-S1 is cellular CaM from the SF9 cells, and not expressed chicken WT CaM.
Fig. 3.
Calcium sensitivity of the MD plus insert (Ins)/CaM complex and converter (Conv) plus insert/CaM monitored by ESI-MS and fluorescence analysis. (A) ESI-MS analysis of the converter plus insert/CaM complex at Vc = 40 V. Addition of 100μM calcium acetate led to saturation of the complex with four Ca2+ bound. Incubation with 10 mM EGTA for 30 min followed by exhaustive dialysis into 50 mM ammonium acetate led to a loss of two Ca2+.(B) Fluorescence spectra of the converter plus insert/CaM complex at 10 μM in 50 mM Hepes (pH 7), 100 mM NaCl, 1 mM DTT, and 10 μM CaCl2, and after addition of either 100 μM CaCl2 or 10 mM EGTA show that loss of Ca2+ from the complex led to a blue shift and decrease of the fluorescence. (C) Fluorescence spectra of the MD plus insert/CaM complex at 10 μM in 10 mM Hepes (pH 7.5), 20 mM NaCl, 2 mM DTT, 1 mM NaN3, 2.5 mM MgCl2, and 100 μM MgATP, and after addition of either 100 μM CaCl2 or 10 mM EGTA did not lead to a significant change in fluorescence.
Beginning with MD plus insert, ESI-MS demonstrated that all of the truncated myosin VI HC complexes bound a single CaM. Mass measurement of the unique species found in solution showed that this complex corresponds to the myosin VI HC with one CaM and four Ca2+ bound. The calcium stoichiometry was confirmed by collision-induced dissociation MS experiments. Increasing the cone voltage to 200 V induces gas phase dissociation of the complex and detection of peaks corresponding to the HC. The mass difference between the so-generated HC and the remaining complex is equal to the mass of one CaM containing four Ca2+. Furthermore, the peak width of the dissociated HC and the intact complex are similar, which indicates that the CaM is bound with a unique Ca2+ stoichiometry. Most remarkably, incubation of the complex with buffers of extremely high (50–250 mM) EGTA concentrations followed by dialysis in 50 mM ammonium acetate did not dissociate these Ca2+ ions from the complex.
We next analyzed the M6-S1 in the absence of added calcium. The predominant population was complexed with two CaM and four calcium although there was also a smaller population with one CaM and four calcium. Thus, consistent with the MD plus insert/CaM analysis, the insert-CaM on the M6-S1 contained four Ca2+ ions after EGTA incubation whereas the IQ-CaM was in the apo form. We had also noted that the M6-S1 would bind an essential light chain (ELC) that we previously used with myosin V (LC-1sa) (17) whereas MD plus insert would not (data not shown). This result demonstrates that the IQ can bind an ELC but the insert cannot. We analyzed an M6-S1 expressed with CaM and ELC by ESI-MS. The predominate species bound one CaM and one ELC. The complex-bound CaM contained four Ca2+, even after preincubation in 5 mM EGTA.
Truncations of the MD Alter CaM-Insert Interactions. The fact that we could not dissociate calcium from the insert-bound CaM, even after dialysis in high concentrations of EGTA, suggested that the CaM-binding site might involve elements of the MD in addition to the insert peptide. To address this question, we next used ESI-MS to analyze fragments that contained only the myosin VI converter plus insert, or the converter plus insert plus IQ motif. In the presence of calcium (100 μM), both CaM lobes in the converter plus insert/CaM complex were occupied by Ca2+ (Fig. 3A). With this construct, high concentrations (10–100 mM) of EGTA were able to dissociate Ca2+ from one of the pairs of lobes of CaM because the predominate complex found in solution had only two Ca2+ bound (Fig. 3A). With the converter plus insert plus IQ, all lobes of the two CaMs were occupied by Ca2+ at 100 μM Ca2+. But again, only two Ca2+ remained bound after EGTA incubation (Table 1). In conclusion, loss of all of the MD except for the converter allows calcium dissociation from only one lobe of the insert-bound CaM.
To obtain further confirmation of nondissociating calcium from the insert-bound CaM, we took advantage of the intrinsic fluorescence of trp within the insert sequence and the ability of CaM or Ca2+–CaM to alter the fluorescence. (The MD has one trp, and the insert has three, whereas there are none in CaM. Changes in CaM conformation on a peptide in response to binding or dissociating Ca2+ will shift the emission of the trp residues and/or enhance or quench fluorescence emission, depending on the effects on local trp environment.) For these experiments we used the MD plus insert/CaM and the converter plus insert/CaM. The converter plus insert/CaM complex demonstrated calcium-sensitive binding, as determined by a 40% decrease in amplitude and shift in the peak emission from 343 nm with Ca2+ to 333 nm in the presence of 10–100 mM EGTA (Fig. 3B). In contrast, the larger MD plus insert/CaM complex was insensitive to EGTA or added calcium (Fig. 3C). Taken together with the ESI-MS data, this result demonstrates that all four Ca2+ ions are bound and do not dissociate from the CaM bound to the insert of the M6-S1 with or without the IQ motif. However, if most of the MD is removed (converter plus insert), then one lobe becomes less constrained and can release and rebind Ca2+. The other CaM lobe interacts with the insert peptide, and possibly elements of the converter, strongly enough to lock calcium into the lobe.
Finally, in the presence of 1 mM Ca2+, the insert peptide alone bound CaM with a 29.2 ± 8.6 nM affinity and peptide:CaM stoichiometry of 1:1.1 (as monitored by trp fluorescence change produced by adding CaM to the insert peptide). In the absence of calcium, the peptide also bound CaM, but we did not perform a titration experiment to establish the binding affinity, given that the insert-CaM does not release calcium in the intact protein.
Calcium Binding to the C-Lobe of CaM Is a Requirement for Binding to the Insert Sequence. To ascertain whether either the N- or C-terminal lobe of the insert-bound CaM has an absolute requirement for Ca2+, we expressed M6-S1, MD plus insert, and converter plus insert with mutants of CaM that destroyed Ca2+-binding at either the N-terminal (E31A; E67A) or C-terminal lobes (E104A; E140A). The C-terminal mutant did not bind to MD plus insert or converter plus insert, as assessed by SDS/PAGE gels or by ESI-MS. The N-terminal mutant bound to both constructs, and ESI-MS revealed that it had two Ca2+ bound whether or not EGTA was present. Fluorescence measurements on the converter plus insert with the N-terminal CaM mutant gave an emission spectra identical to WT CaM in the presence of EGTA, indicating that the N-terminal lobe loses Ca2+ in that complex.
Similar conclusions were derived from the M6-S1. As shown in the SDS/PAGE gel of Fig. 2B, overexpression of the N-terminal CaM mutant saturated the two M6-S1 CaM-binding sites whereas overexpression of the C-terminal mutant led to an ≈1:1 mix of WT (SF9) and mutant CaM bound to the HC. These results clearly show that calcium binding to the C-terminal lobe of CaM is required for the CaM to bind to the insert if an intact converter is present. Although binding can take place with calcium not bound to the N-terminal lobe, ESI-MS measurements show that, for the constructs with an intact MD, calcium normally occupies all four binding sites on CaM bound to the myosin VI insert.
Fitting the trp titration data produced by binding of the N-terminal mutant CaM to the insert peptide in the presence of 1 mM Ca2+ revealed a dissociation constant of 36.1 ± 17.8 nM affinity and a 1:1.94 peptide:CaM stoichiometry. The unusual stoichiometry likely arises from two different CaMs binding to the peptide by their calcium-bound C-terminal lobes. The somewhat decreased affinity and unusual stoichiometry suggest that, although calcium binding to the amino-terminal lobe is not essential for CaM binding, it does contribute to the free energy of binding to the myosin VI insert. The C-terminal mutant did not give a 1:1 stoichiometry and seemed to bind much more weakly to the insert peptide. Thus, the Ca2+-bound C-lobe of CaM is binding with higher affinity to the insert peptide than is the N-terminal lobe.
We compared the fluorescence red shift of the Ca2+–CaM/insert peptide complex after incubation in 50 mM EGTA to the fluorescence of the WT and N-terminal mutant CaM/insert peptide complexes formed either in Ca2+ or EGTA conditions. Addition of EGTA led to a red-shifted emission maximum from 342 to 350 nm. This result indicates a complex that had retained Ca2+ in at least one lobe because it clearly differs from the spectra of the complex formed between apo-CaM and the peptide (whose maximum is 352 nm). This finding suggests that the interaction of the C-lobe of CaM with the insert peptide is sufficient to greatly inhibit the dissociation of the Ca2+ ions from this lobe.
The IQ-Bound CaM. The ESI-MS data on the M6-S1 and converter plus insert plus IQ constructs revealed that a CaM without bound calcium was associated to the IQ motif in the majority of the complexes in EGTA conditions. However, the IQ site was not completely saturated with CaM. We thus created a construct we called M6-long S1 that contained a region (79 aa) of unknown structure that has low probability of being coiled-coil (<30%). ESI-MS revealed that M6-long S1 bound two CaMs and four Ca2+ ions if exogenous calcium was not added. In this case, there was no detectable loss of CaM from the HC, suggesting that the affinity for the IQ-bound CaM was increased by some part of the C-terminal sequence in the M6-long S1.
ESI-MS data on the M6-S1 and the converter plus insert plus IQ in the presence of calcium revealed an HC population with two CaM and eight bound calcium, but also HC dimers (minor population) with three CaM and 12 bound calcium. This result suggests that at least one lobe of the IQ-CaM can dissociate in the presence of calcium and reassociate, either with the same IQ motif or with an IQ motif of another HC, which gives dimerization. This dimerization did not occur with the M6-long S1 construct, which was a single population of one HC and two CaM at 300 μM Ca2+. This result further suggests that there may be an interaction of the IQ-CaM with elements C-terminal to the IQ motif that alter interactions of the N-terminal lobe of the IQ-CaM.
To characterize the CaM affinity for the IQ motif, the effect of CaM titration on the trp fluorescence of the IQ peptide was determined. In the presence of excess EGTA (0.5 mM), the IQ-peptide was not saturated with CaM, even with 15 μM CaM and 2 μM peptide. In the presence of calcium (1 mM), the stoichiometry of binding to the IQ peptide was 2 peptides:1 CaM, demonstrating a lack of cooperativity in the two lobes of CaM on either side of the peptide. Moreover, the CaM affinity seemed much weaker than in the case of the insert peptide. This result is consistent with the weak association of CaM with the IQ site in the M6-S1 and converter plus insert plus IQ constructs.

Discussion

The fact that CaM binds to the unique insert in myosin VI between the converter domain and IQ motif was totally unexpected. However, it should be noted that, when porcine myosin VI was first described by Hasson et al. (6), they speculated that this insert might bind a unique myosin light chain that could serve a regulatory role. This suggestion was later disregarded because the insert sequence does not match that of any known CaM or myosin light chain binding sequences, and expressed functional myosin VI proteins contained only CaM.
This structural interaction of the Ca2+ with the insert-CaM is truly remarkable in that the Ca2+ ions cannot dissociate from either lobe of CaM when an intact MD precedes the insert. With removal of all of the MD elements other than the converter, the N-terminal lobe is free to exchange calcium. This finding implies that there must be direct interactions between the N-terminal lobe of CaM and regions of the MD outside of the converter and perhaps additional ones with the converter itself. Such interactions are not without precedent. For example, in the case of CaM binding to myosin light chain kinase, CaM interactions with regions of the protein outside of the CaM-binding peptide alter the CaM affinity for Ca2+ at both the N- and C-terminal lobes (18). Because CaM has many different targets in the cell, such tuning of the thresholds and time courses for Ca2+ dissociation by the rest of the protein is physiologically important and allows CaM to play both structural and regulatory roles in the cell.
Saturation of both lobes of the insert-CaM with Ca2+ is necessary for normal myosin VI motor function. Measurements with the N-terminal mutant CaM bound to both CaM sites on myosin VI showed decreased rates of ADP release and motility of myosin VI (12). In the case of the C-terminal lobe, calcium could not be removed from any of our complexes, and the C-lobe mutant CaM did not form complexes in either bacteria or SF9 cells. Thus, a Ca2+-bound C-terminal lobe of CaM is absolutely necessary for binding to the insert peptide.
Given that the calcium does not dissociate from the CaM bound to the insert of myosin VI, it is clearly not playing a regulatory role. Rather, we suggest that it is a critical structural component of the converter itself. Its likely role is to reposition the IQ motif so that it points toward the minus end of the actin filament when myosin VI is strongly attached to actin. In fact the cryo-electron microscopy density ascribed to the unusual myosin VI converter by Wells et al. (1) cannot easily be accounted for by the insert alone. It is likely to be comprised of the insert with Ca2+-CaM bound. The fact that the Ca2+ does not dissociate from either the C-terminal lobe or N-terminal lobe of the insert-bound CaM insures that changing cellular Ca2+ concentrations does not perturb the converter plus insert/CaM structure.
CaM binding to the IQ motif is not calcium-dependent, and both lobes likely are in the apo form under resting cellular Ca2+ concentrations. Calcium binding to this IQ motif-bound CaM can detach at least one of its lobes in the S1 construct. Previous studies (12, 19) suggest that CaM does not dissociate from dimeric myosin VI, even at high Ca2+ concentrations. Calcium concentrations in the mM range alter the activity of myosin VI and cause uncoupling of the two heads (12). This effect is due to calcium binding to the N-terminal lobe of CaM. Given the results shown herein, the regulatory site is the N-terminal lobe of the IQ-CaM. The exact nature of the regulation is unclear, but calcium must change the nature and/or site of the binding of the N-terminal lobe of the IQ-CaM. Further work on the IQ-peptide and sequences C-terminal to the IQ motif are necessary to delineate the mechanism of this regulation.
The IQ peptide revealed relatively weak binding (>100 nM) to CaM that did not produce a 1:1 stoichiometry, reinforcing the assertion that elements outside of the IQ motif may contribute to CaM binding in the intact protein. This weak binding is somewhat surprising. However, the myosin VI IQ motif does deviate from the consensus sequence (IQxxxRGxxxR/K) in that the glycine consensus residue is found to be a methionine. Based on previous structures, this result would be predicted to prevent close interaction between the N-terminal lobe of CaM and the IQ peptide (20, 21). Additionally, there is another methionine in place of the consensus isoleucine. Although a bulky residue is commonly found in essential light chain-binding IQ motifs, this bulky side-chain could weaken the binding of the C-terminal lobe of CaM. The CaM–IQ interaction was greatly strengthened by residues C-terminal to the IQ motif. However, it is a formal possibility that the relatively weak interaction of the IQ motif itself with CaM indicates that it binds some light chain other than CaM in vivo.
It is clear that tissue-purified myosin VI from pig has CaM bound to it (6). What is not clear is whether or not CaM is the only light chain associated with myosin VI. Based on our analysis in this article, only a light chain with four competent EF-hand calcium-binding sites can bind optimally to the unique insert of myosin VI. Thus, the tissue-purified myosin VI must have CaM bound to the insert peptide. The identity of the light chain bound to the IQ motif of myosin VI is less certain, and given that it can bind an ELC as well as CaM, it could be occupied by a different light chain in vivo, perhaps even in a tissue-specific manner. Additional data that we did not show in the article demonstrate that, if one does not coexpress exogenous light chains or CaM in SF9 cells, then the myosin VI that is purified has two endogenous CaMs bound to each head. Thus, in the case of SF9 cells, there is no endogenous light chain that can compete with CaM at either myosin VI binding site.
The sequence that strengthens the CaM-IQ interaction is immediately C-terminal to the IQ motif and has a low probability of forming coiled coil. This sequence is likely to play a fundamental role in the movement of myosin VI. Rock et al. (9) measured the average step size of myosin VI and demonstrated that it is much larger than is possible with a lever arm comprised of a single IQ motif (30 nm vs. 5 nm; see ref. 5). Because of the large distribution of step sizes (including positive and negative steps), they postulated that a flexible element allows biased diffusion of the myosin VI head, and that this region of weak coiled coil may contribute to that flexible element. Given that the insert-CaM seems to be locking itself onto the converter, perhaps to redirect movement, the search for a flexible domain within the myosin VI motor must now be focused on the structural elements C-terminal to the IQ motif and the IQ motif itself. This region may contribute to the effective lever arm of myosin VI. If so, it must have regions of high flexibility as compared with the lever arms of other characterized myosin family members.

Notes

This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: CaM, calmodulin; ESI, electrospray ionization; MD, motor domain; ELC, essential light chain; TOF, time-of-flight; HC, heavy chain; trp, tryptophan.

Acknowledgments

This work was supported by National Institutes of Health Grant AR-048931 (to H.L.S. and A.H.), by grants from the Centre National de la Recherche Scientifique and the Association pour la Recherche sur le Cancer (to A.H.), as well as predoctoral fellowships from the Quebec government and the Fondation pour la Recherche Médicale (to A.B.). G.C. gratefully thanks the Centre National de la Recherche Scientifique and Aventis for financial support.

References

1
Wells, A. L., Lin, A. W., Chen, L.-Q., Safer, D., Cain, S. M., Hasson, T., Carragher, B. O., Milligan, R. A. & Sweeney, H. L. (1999) Nature 401, 505–508.
2
Cheney, R. E. & Mosseker, M. S. (1992) Curr. Opin. Cell Biol. 4, 27–35.
3
Holmes, K. C. & Geeves, M. A. (1999) Annu. Rev. Biochem. 68, 687–728.
4
Houdusse, A. & Sweeney, H. L. (2001) Curr. Opin. Struct. Biol. 11, 182–194.
5
Purcell, T. J., Morris, C., Spudich, J. A. & Sweeney, H. L. (2002) Proc. Natl. Acad. Sci. USA 99, 14159–14164.
6
Hasson, T. & Mooseker, M. S. (1994) J. Cell Biol. 127, 425–440.
7
Uyeda, T. Q., Abramson, P. D. & Spudich, J. A. (1996) Proc. Natl. Acad. Sci. USA 93, 4459–4464.
8
Sakamoto, T., Wang, F., Schmitz, S., Xu, Y., Xu, Q., Molloy, J. E., Veigel, C. & Sellers, J. R. (2003) J. Biol. Chem. 278, 29201–29207.
9
Rock, R. S., Rice, S. E., Wells, A. L., Purcell, T. J., Spudich, J. A. & Sweeney, H. L. (2001) Proc. Natl. Acad. Sci. USA 98, 13655–13659.
10
Hopp, T. P., Prickett, K. S., Price, V., Libby, R. T., March, C. J., Cerretti, P., Urdal, D. L. & Conlon, P. J. (1988) Biotechnology 6, 1205–1210.
11
Sweeney, H. L., Rosenfeld, S., Brown, F., Faust, L., Smith, J., Stein, L. & Sellers, J. (1998) J. Biol. Chem. 273, 6262–6270.
12
Morris, C. A., Wells, A. L., Yang, Z., Chen, L. Q., Baldacchino, C. V. & Sweeney, H. L. (2003) J. Biol. Chem. 278, 23324–23330.
13
Maune, J. F., Klee, C. B. & Beckingham, K. (1992) J. Biol. Chem. 267, 5286–5295.
14
Loo, J. A. (1997) Mass Spectrom. Rev. 16, 1–23.
15
Hunter, C. L., Mauk, A. G. & Douglas, D. J. (1997) Biochemistry 36, 1018–1025.
16
Nousiainen, M., Derrick, P. J., Lafitte, D. & Vainiotalo, P. (2003) Biophys. J. 85, 491–500.
17
De La Cruz, E. M., Wells, A. L., Rosenfeld, S. S., Ostap, E. M. & Sweeney, H. L. (1999) Proc. Natl. Acad. Sci. USA. 96, 13726–13731.
18
Peersen, O. B., Madsen, T. S. & Falke, J. J. (1997) Protein Sci. 6, 794–807.
19
Homma, K., Saito, J., Ikebe, R. & Ikebe, M. J. Biol. Chem. 275, 34766–34771.
20
Houdusse, A., Silver, M. & Cohen, C. (1996) Structure 4, 1475–1490.
21
Terrak, M., Wu, G., Stafford, W. F., Lu, R. C. & Dominguez, R. (2003) EMBO J. 22, 362–371.

Information & Authors

Information

Published in

Go to Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences
Vol. 101 | No. 14
April 6, 2004
PubMed: 15037754

Classifications

Submission history

Received: October 24, 2003
Published online: March 22, 2004
Published in issue: April 6, 2004

Acknowledgments

This work was supported by National Institutes of Health Grant AR-048931 (to H.L.S. and A.H.), by grants from the Centre National de la Recherche Scientifique and the Association pour la Recherche sur le Cancer (to A.H.), as well as predoctoral fellowships from the Quebec government and the Fondation pour la Recherche Médicale (to A.B.). G.C. gratefully thanks the Centre National de la Recherche Scientifique and Aventis for financial support.

Authors

Affiliations

Amel Bahloul
Structural Motility, Institut Curie Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144, 26 Rue d'Ulm, 75248 Paris Cedex 05, France; Laboratoire de Spectrométrie de Masse Bio-Organique, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7509, 25 Rue Becquerel, 67087 Strasbourg Cedex 2, France; Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; and Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294
Guillaume Chevreux
Structural Motility, Institut Curie Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144, 26 Rue d'Ulm, 75248 Paris Cedex 05, France; Laboratoire de Spectrométrie de Masse Bio-Organique, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7509, 25 Rue Becquerel, 67087 Strasbourg Cedex 2, France; Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; and Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294
Amber L. Wells
Structural Motility, Institut Curie Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144, 26 Rue d'Ulm, 75248 Paris Cedex 05, France; Laboratoire de Spectrométrie de Masse Bio-Organique, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7509, 25 Rue Becquerel, 67087 Strasbourg Cedex 2, France; Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; and Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294
Davy Martin
Structural Motility, Institut Curie Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144, 26 Rue d'Ulm, 75248 Paris Cedex 05, France; Laboratoire de Spectrométrie de Masse Bio-Organique, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7509, 25 Rue Becquerel, 67087 Strasbourg Cedex 2, France; Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; and Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294
Jocelyn Nolt
Structural Motility, Institut Curie Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144, 26 Rue d'Ulm, 75248 Paris Cedex 05, France; Laboratoire de Spectrométrie de Masse Bio-Organique, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7509, 25 Rue Becquerel, 67087 Strasbourg Cedex 2, France; Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; and Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294
Zhaohui Yang
Structural Motility, Institut Curie Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144, 26 Rue d'Ulm, 75248 Paris Cedex 05, France; Laboratoire de Spectrométrie de Masse Bio-Organique, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7509, 25 Rue Becquerel, 67087 Strasbourg Cedex 2, France; Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; and Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294
Li-Qiong Chen
Structural Motility, Institut Curie Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144, 26 Rue d'Ulm, 75248 Paris Cedex 05, France; Laboratoire de Spectrométrie de Masse Bio-Organique, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7509, 25 Rue Becquerel, 67087 Strasbourg Cedex 2, France; Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; and Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294
Noëlle Potier
Structural Motility, Institut Curie Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144, 26 Rue d'Ulm, 75248 Paris Cedex 05, France; Laboratoire de Spectrométrie de Masse Bio-Organique, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7509, 25 Rue Becquerel, 67087 Strasbourg Cedex 2, France; Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; and Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294
Alain Van Dorsselaer
Structural Motility, Institut Curie Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144, 26 Rue d'Ulm, 75248 Paris Cedex 05, France; Laboratoire de Spectrométrie de Masse Bio-Organique, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7509, 25 Rue Becquerel, 67087 Strasbourg Cedex 2, France; Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; and Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294
Steve Rosenfeld
Structural Motility, Institut Curie Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144, 26 Rue d'Ulm, 75248 Paris Cedex 05, France; Laboratoire de Spectrométrie de Masse Bio-Organique, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7509, 25 Rue Becquerel, 67087 Strasbourg Cedex 2, France; Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; and Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294
Anne Houdusse
Structural Motility, Institut Curie Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144, 26 Rue d'Ulm, 75248 Paris Cedex 05, France; Laboratoire de Spectrométrie de Masse Bio-Organique, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7509, 25 Rue Becquerel, 67087 Strasbourg Cedex 2, France; Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; and Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294
H. Lee Sweeney
Structural Motility, Institut Curie Centre National de la Recherche Scientifique, Unité Mixte de Recherche 144, 26 Rue d'Ulm, 75248 Paris Cedex 05, France; Laboratoire de Spectrométrie de Masse Bio-Organique, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 7509, 25 Rue Becquerel, 67087 Strasbourg Cedex 2, France; Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104; and Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294

Notes

To whom correspondence should be addressed. E-mail: [email protected].
Edited by James A. Spudich, Stanford University School of Medicine, Stanford, CA, and approved January 21, 2004

Metrics & Citations

Metrics

Note: The article usage is presented with a three- to four-day delay and will update daily once available. Due to ths delay, usage data will not appear immediately following publication. Citation information is sourced from Crossref Cited-by service.


Citation statements




Altmetrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

Cited by

    Loading...

    View Options

    View options

    PDF format

    Download this article as a PDF file

    DOWNLOAD PDF

    Login options

    Check if you have access through your login credentials or your institution to get full access on this article.

    Personal login Institutional Login

    Recommend to a librarian

    Recommend PNAS to a Librarian

    Purchase options

    Purchase this article to access the full text.

    Single Article Purchase

    The unique insert in myosin VI is a structural calcium–calmodulin binding site
    Proceedings of the National Academy of Sciences
    • Vol. 101
    • No. 14
    • pp. 4721-5181

    Media

    Figures

    Tables

    Other

    Share

    Share

    Share article link

    Share on social media